SCHEMBL15215604

SCHEMBL15215604

Cc1cc2[nH]c(=S)n(N(C)C)c(=O)c2cc1C

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MPO P05164 7/20 0.67
▸ XDH P47989 6/20 0.67
▸ CA12 O43570 1/20 0.45
▸ CA1 P00915 1/20 0.45
▸ CA2 P00918 1/20 0.45
▸ CA9 Q16790 1/20 0.45
▸ ALDH1A1 P00352 6/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ GRIN2D O15399 1/20 0.37
▸ GRIN3B O60391 1/20 0.37
▸ GRIN1 Q05586 1/20 0.37
▸ GRIN2A Q12879 1/20 0.37
▸ GRIN2B Q13224 1/20 0.37
▸ GRIN2C Q14957 1/20 0.37
▸ GRIN3A Q8TCU5 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ PKM P14618 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15215603 0.81 MPO (0.59) MPOXDHCA12CA1CA2
SCHEMBL2731141 0.80 MPO (1.00) MPOXDHALDH1A1POLBPKM
SCHEMBL15215608 0.77 CA12 (0.47) MPOXDHCA12CA1CA2
SCHEMBL15215601 0.77 MPO (0.66) MPOXDHCA12CA1CA2
SCHEMBL2730985 0.71 KMT2A (0.67) MPOXDHALDH1A1KDM4EHPGD
SCHEMBL10288998 0.70 MPO (0.56) MPOXDHCA12CA1CA2
SCHEMBL15215606 0.69 MPO (0.53) MPOXDHALDH1A1PKMHTT
SCHEMBL15215605 0.68 MPO (0.55) MPOXDHALDH1A1HTTHSD17B10
SCHEMBL13953176 0.63 KDM4E (0.50) ALDH1A1KDM4EHPGDGRIN2DGRIN3B
SCHEMBL13560656 0.63 GRIN2D (0.52) ALDH1A1KDM4EHPGDGRIN2DGRIN3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130225612-A1 QUINAZOLINE DERIVATIVES, COMPOSITIONS, AND USES RELATED THERETO EMORY UNIVERSITY (US) 2013-08-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130225612-A1 QUINAZOLINE DERIVATIVES, COMPOSITIONS, AND USES RELATED THERETO NOX4, NOX5, NQO2 MPO 10/4885XDH 11/4885CA12 4261/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback